8 results about "Abelmoschus" patented technology

The present application relates to the technical field of analysis, in particular to a combined analysis method for analyzing the chemical components of Huangkui capsules, which is a fast, efficient and accurate method for analyzing the chemical components of Huangkui capsules based on UHPLC-Q-TOF / MS combined with MS-DIAL and GNPS strategy. By setting conditions such as positive and negative ion mode full scan, molecular ion peak pairing, accurate molecular weight mass error and isotope peak abundance, the compounds can be accurately identified, the molecular formula is generated, and the identification of the compounds is completed based on the self-built compound database. Further combined with MS-DIAL and GNPS, two molecular cages related to flavonoid structure are successfully identified according to MS / MS similarity, and a total of 13 compounds other than the self-built compound database are identified. It provides a useful reference for further development and utilization of Huangkui capsules.

The invention discloses an edible and medicinal composition solid beverage and a preparation method thereof. The beverage is prepared from the following raw materials in percentage by weight: 45-60% of a traditional Chinese medicine extract, 10-18% of energy and flavor components, 27-38% of a sweetening agent and 0.01-0.5% of a stabilizer. The energy and flavor components of the edible and medicinal composition solid beverage disclosed by the invention adopt coconut oil powder and green kumquat raw powder, so that the taste is suitable for most people; the sweetening agent is a combination of erythritol, stevioside and sweet essence, so that sugar metabolism in the body is avoided, and the worry of rising sugar is avoided; starch sodium octenylsuccinate, ovalbumin, locust bean gum and abelmoschus esculentus colloid polysaccharide are adopted as stabilizers, so that the beverage is uniform and stable after being flushed with water and is not easy to settle.

The invention discloses a method for analyzing an anti-inflammatory mechanism of total flavonoids of abelmoschus manihot based on UHPLC-QTOF-MS (Ultra High Performance Liquid Chromatography-Quantitative Time of Flight Mass Spectrometry) cell metabonomics. The method comprises the following steps: optimizing extraction conditions of a metabonomics intracellular sample, inducing RAW 264.7 cells by utilizing lipopolysaccharide (LPS) to construct an inflammation model, extracting the intracellular sample by adopting an optimized extraction mode, and then separating and identifying intracellular metabolites of a control group, a model group and an administration group (medium, low and high TFA (total flavonoids of abelmoschus manihot) dosage groups) by utilizing a UHPLC-Q-TOF-MS (Ultra High Performance Liquid Chromatography-Quantitative Time of Flight Mass Spectrometry) method. Analyzing the obtained secondary mass spectrum data, screening out differential compounds in the three groups by utilizing multivariate variable statistical analysis, and identifying the differential compounds; metaboAnalyst 6.0 is used for carrying out enrichment analysis and metabolic pathway analysis on the screened differential metabolites, and the possible anti-inflammatory activity mechanism of the differential metabolites influencing the total flavonoids of the abelmoschus manihot is clarified. The invention provides an effective metabonomics analysis method for illuminating an anti-inflammatory activity mechanism of the total flavonoids of the abelmoschus manihot flowers.

The invention relates to the technical field of preparation of pectic polysaccharides, in particular to an abelmoschus manihot flower pectic polysaccharide as well as a preparation method and application thereof. The total sugar content of the abelmoschus manihot flower pectic polysaccharide is greater than or equal to 82%; the abelmoschus manihot flower pectic polysaccharide comprises mannose, rhamnose, galacturonic acid, glucose and arabinose. The amount of substance n1 of mannose, the amount of substance n2 of rhamnose, the amount of substance n3 of galacturonic acid, the amount of substance n4 of glucose and the amount of substance n5 of arabinose meet the following condition: n1: n2: n3: n4: n5 = 0.01: 0.15: 4.76: 1.21: 0.90: 0.15. According to the abelmoschus manihot flower pectic polysaccharide, the immunoregulation effect of the abelmoschus manihot flower pectic polysaccharide is improved through a specific combination of galacturonic acid (main chain charge binding), side chain monosaccharide (conformation optimization) and mannose (targeted activation) on the basis that the total sugar content is larger than or equal to 82%.

The invention discloses a mild tightening, whitening and spot-fading plant composition and a preparation method thereof, and belongs to the technical field of cosmetics. The composition comprises the following components in parts by weight: 15-22 parts of a silybum marianum extract, 4-9 parts of a tuber melanosporum extract, 12-18 parts of an abelmoschus esculentus fruit extract, 5-10 parts of a chlorella fermentation product and 3-8 parts of a bakusnea leaf extract. The composition achieves the effects of multi-channel whitening (covering melanin generation, oxidation, transport and metabolism whole links), anti-inflammatory repair and tightening and moisturizing through the synergistic effect of multiple components, is mild and low in irritation, is suitable for various skin types including sensitive skin and can be widely used for preparing cosmetics, the adding amount is 0.1 wt%-20 wt%, and the skin whitening effect is good. The product efficacy and the skin tolerance can be effectively considered.

The application discloses anti-inflammatory toothpaste based on Dendrobium huoshanense stem extract and a preparation method thereof, and relates to the technical field of toothpaste.The anti-inflammatory toothpaste contains the following raw materials in parts by weight: friction agent 20-30 parts, humectant 15-30 parts, emulsifier 1-2 parts, thickening agent 1-2.5 parts, Dendrobium huoshanense stem extract 1-3 parts, Abelmoschus flower extract 0.5-1.5 parts, Perilla leaf extract 0.5-1.5 parts, anti-allergic agent 3.5-7.5 parts, auxiliary material 1-3.5 parts, and deionized water 20-40 parts.The specific plant extract and the Dendrobium huoshanense stem extract are synergistically used, and the basic formula system is optimized, so that the comprehensive anti-inflammatory effect of the product is effectively improved, and the stability and mildness of the toothpaste are improved.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for preventing and / or treating renal anemia, a preparation, a preparation method and application. The invention provides a traditional Chinese medicine composition for preventing and / or treating renal anemia, which is prepared from the following ingredients in parts by mass: 10 to 30 parts of turtle shells, 10 to 30 parts of radix astragali seu hedysari, 10 to 40 parts of seaweed, 15 to 30 parts of raw oyster shells, 2 to 5 parts of leeches, 5 to 15 parts of radix angelicae sinensis, 10 to 30 parts of rhizoma chuanxiong and 5 to 20 parts of abelmoschus manihot flowers. The embodiment shows that the turtle shell anti-aging liquid has the effect of improving the hemoglobin level, the red blood cell number and the renal function of a patient, the curative effect of the turtle shell anti-aging liquid is obviously superior to that of a nephritis anti-aging liquid formula and a Chinese patent medicine abelmoschus esculentus capsule, the turtle shell anti-aging liquid does not have obvious damage to the liver function, is high in safety, has the advantage of adjusting imbalance of electrolyte and acid-base balance level, and can be used for treating nephritis. The traditional Chinese medicine composition can delay renal tissue fibrosis and apoptosis and regulate renal anemia related pathways, is lower in cost, and can effectively relieve renal anemia and delay the progress of chronic kidney diseases.

The application provides application of ipomoea nil exocyst in preparation of a medicine for preventing, alleviating or treating osteomyelitis. The application creatively finds that the ipomoea nil exocyst can significantly inhibit the expression of macrophage pyroptosis markers GSDMD-NT and Caspase-1, promote the expression of osteogenesis markers RUNX2 and OPN, and mediate immune regulation to achieve the treatment of osteomyelitis. The ipomoea nil exocyst is loaded in a three-dimensional cross-linked skeleton formed by oxidized dextran, aminopolysaccharide and gelatin, has better mass transfer delivery effect, and significantly improves the treatment effect on osteomyelitis.